Skip to content

Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood

The Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01734590
Enrollment
12
Registered
2012-11-27
Start date
2012-11-30
Completion date
2012-12-31
Last updated
2013-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Flour,, carbohydrate,, digestibility, subjects

Brief summary

Exploratory study with double-blind, randomized, placebo-controlled, full cross-over design. The main objective is to identify one or two flour compositions in a carbohydrate-based food that produce a significant difference (alpha =0.2) in the time to reach 50% of cumulative absorption of exogenous glucose compared to the control.

Detailed description

Twelve volunteers will participate in the study; each person will be studied on three different occasions at least one week apart, consuming the three different test products in a randomized order. Test products are carbohydrate-based food made from different flour mixes differing in their expected rate of intestinal starch digestion. The products are labeled with 13C starch.

Interventions

DIETARY_SUPPLEMENTCarbohydrate based food mix 1

Carbohydrate based food

DIETARY_SUPPLEMENTCarbohydrate based food mix 2

Carbohydrate based food

DIETARY_SUPPLEMENTControl carbohydrate based food

Carbohydrate based food

Sponsors

Unilever R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy males * Age at start of the study ≥18 and ≤ 50 years * Not smoking * Body mass index (BMI) ≥ 20 and ≤ 28 kg/m2 * Fasting blood glucose value of volunteer is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening

Design outcomes

Primary

MeasureTime frame
Rate of appearance of exogenous glucose (RaE) based on the dual isotope technique.Measured during 360 min for 3 periods

Secondary

MeasureTime frame
Total blood glucose and insulinMeasured during 360 min for 3 periods

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026